 | • レポートコード：QY2203B11698 • 出版社/出版日：QYResearch / 2022年3月18日 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界の前部ブドウ膜炎治療薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に前部ブドウ膜炎治療薬の世界市場のxxx％を占める「ダラザチド」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「診療所」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の前部ブドウ膜炎治療薬の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの前部ブドウ膜炎治療薬市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの前部ブドウ膜炎治療薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 前部ブドウ膜炎治療薬のグローバル主要メーカーには、Aciont Inc.、Aldeyra Therapeutics, Inc.、EyeGate Pharmaceuticals, Inc.、KPI Therapeutics, Inc.、Neuroptis Biotechなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 前部ブドウ膜炎治療薬市場は、種類と用途によって区分されます。世界の前部ブドウ膜炎治療薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 ダラザチド、LME-636、NOP-3、その他 【用途別セグメント】 診療所、病院、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 前部ブドウ膜炎治療薬製品概要 - 種類別市場（ダラザチド、LME-636、NOP-3、その他） - 用途別市場（診療所、病院、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の前部ブドウ膜炎治療薬販売量予測2017-2028 - 世界の前部ブドウ膜炎治療薬売上予測2017-2028 - 前部ブドウ膜炎治療薬の地域別販売量 - 前部ブドウ膜炎治療薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別前部ブドウ膜炎治療薬販売量 - 主要メーカー別前部ブドウ膜炎治療薬売上 - 主要メーカー別前部ブドウ膜炎治療薬価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（ダラザチド、LME-636、NOP-3、その他） - 前部ブドウ膜炎治療薬の種類別販売量 - 前部ブドウ膜炎治療薬の種類別売上 - 前部ブドウ膜炎治療薬の種類別価格 ・用途別市場規模（診療所、病院、その他） - 前部ブドウ膜炎治療薬の用途別販売量 - 前部ブドウ膜炎治療薬の用途別売上 - 前部ブドウ膜炎治療薬の用途別価格 ・北米市場 - 北米の前部ブドウ膜炎治療薬市場規模（種類別、用途別） - 主要国別の前部ブドウ膜炎治療薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの前部ブドウ膜炎治療薬市場規模（種類別、用途別） - 主要国別の前部ブドウ膜炎治療薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の前部ブドウ膜炎治療薬市場規模（種類別、用途別） - 主要国別の前部ブドウ膜炎治療薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の前部ブドウ膜炎治療薬市場規模（種類別、用途別） - 主要国別の前部ブドウ膜炎治療薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの前部ブドウ膜炎治療薬市場規模（種類別、用途別） - 主要国別の前部ブドウ膜炎治療薬市場規模（トルコ、サウジアラビア） ・企業情報 Aciont Inc.、Aldeyra Therapeutics, Inc.、EyeGate Pharmaceuticals, Inc.、KPI Therapeutics, Inc.、Neuroptis Biotech ・産業チェーン及び販売チャネル分析 - 前部ブドウ膜炎治療薬の産業チェーン分析 - 前部ブドウ膜炎治療薬の原材料 - 前部ブドウ膜炎治療薬の生産プロセス - 前部ブドウ膜炎治療薬の販売及びマーケティング - 前部ブドウ膜炎治療薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 前部ブドウ膜炎治療薬の産業動向 - 前部ブドウ膜炎治療薬のマーケットドライバー - 前部ブドウ膜炎治療薬の課題 - 前部ブドウ膜炎治療薬の阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Anterior Uveitis Drug Market
Due to the COVID-19 pandemic, the global Anterior Uveitis Drug market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Dalazatide accounting for % of the Anterior Uveitis Drug global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Clinic segment is altered to an % CAGR throughout this forecast period.
China Anterior Uveitis Drug market size is valued at US$ million in 2021, while the US and Europe Anterior Uveitis Drug are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Anterior Uveitis Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Anterior Uveitis Drug include Aciont Inc., Aldeyra Therapeutics, Inc., EyeGate Pharmaceuticals, Inc., KPI Therapeutics, Inc. and Neuroptis Biotech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Anterior Uveitis Drug Scope and Segment
Anterior Uveitis Drug market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Anterior Uveitis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Dalazatide
LME-636
NOP-3
Others
Segment by Application
Clinic
Hospital
Others
By Company
Aciont Inc.
Aldeyra Therapeutics, Inc.
EyeGate Pharmaceuticals, Inc.
KPI Therapeutics, Inc.
Neuroptis Biotech
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
1 Study Coverage
1.1 Anterior Uveitis Drug Product Introduction
1.2 Market by Type
1.2.1 Global Anterior Uveitis Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Dalazatide
1.2.3 LME-636
1.2.4 NOP-3
1.2.5 Others
1.3 Market by Application
1.3.1 Global Anterior Uveitis Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Anterior Uveitis Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Anterior Uveitis Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Anterior Uveitis Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Anterior Uveitis Drug Sales by Region
2.4.1 Global Anterior Uveitis Drug Sales by Region (2017-2022)
2.4.2 Global Sales Anterior Uveitis Drug by Region (2023-2028)
2.5 Global Anterior Uveitis Drug Revenue by Region
2.5.1 Global Anterior Uveitis Drug Revenue by Region (2017-2022)
2.5.2 Global Anterior Uveitis Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Anterior Uveitis Drug Sales by Manufacturers
3.1.1 Global Top Anterior Uveitis Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Anterior Uveitis Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anterior Uveitis Drug in 2021
3.2 Global Anterior Uveitis Drug Revenue by Manufacturers
3.2.1 Global Anterior Uveitis Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Anterior Uveitis Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Anterior Uveitis Drug Revenue in 2021
3.3 Global Anterior Uveitis Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Anterior Uveitis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Anterior Uveitis Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Anterior Uveitis Drug Sales by Type
4.1.1 Global Anterior Uveitis Drug Historical Sales by Type (2017-2022)
4.1.2 Global Anterior Uveitis Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Anterior Uveitis Drug Sales Market Share by Type (2017-2028)
4.2 Global Anterior Uveitis Drug Revenue by Type
4.2.1 Global Anterior Uveitis Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Anterior Uveitis Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Anterior Uveitis Drug Revenue Market Share by Type (2017-2028)
4.3 Global Anterior Uveitis Drug Price by Type
4.3.1 Global Anterior Uveitis Drug Price by Type (2017-2022)
4.3.2 Global Anterior Uveitis Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Anterior Uveitis Drug Sales by Application
5.1.1 Global Anterior Uveitis Drug Historical Sales by Application (2017-2022)
5.1.2 Global Anterior Uveitis Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Anterior Uveitis Drug Sales Market Share by Application (2017-2028)
5.2 Global Anterior Uveitis Drug Revenue by Application
5.2.1 Global Anterior Uveitis Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Anterior Uveitis Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Anterior Uveitis Drug Revenue Market Share by Application (2017-2028)
5.3 Global Anterior Uveitis Drug Price by Application
5.3.1 Global Anterior Uveitis Drug Price by Application (2017-2022)
5.3.2 Global Anterior Uveitis Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Anterior Uveitis Drug Market Size by Type
6.1.1 North America Anterior Uveitis Drug Sales by Type (2017-2028)
6.1.2 North America Anterior Uveitis Drug Revenue by Type (2017-2028)
6.2 North America Anterior Uveitis Drug Market Size by Application
6.2.1 North America Anterior Uveitis Drug Sales by Application (2017-2028)
6.2.2 North America Anterior Uveitis Drug Revenue by Application (2017-2028)
6.3 North America Anterior Uveitis Drug Market Size by Country
6.3.1 North America Anterior Uveitis Drug Sales by Country (2017-2028)
6.3.2 North America Anterior Uveitis Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Anterior Uveitis Drug Market Size by Type
7.1.1 Europe Anterior Uveitis Drug Sales by Type (2017-2028)
7.1.2 Europe Anterior Uveitis Drug Revenue by Type (2017-2028)
7.2 Europe Anterior Uveitis Drug Market Size by Application
7.2.1 Europe Anterior Uveitis Drug Sales by Application (2017-2028)
7.2.2 Europe Anterior Uveitis Drug Revenue by Application (2017-2028)
7.3 Europe Anterior Uveitis Drug Market Size by Country
7.3.1 Europe Anterior Uveitis Drug Sales by Country (2017-2028)
7.3.2 Europe Anterior Uveitis Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Anterior Uveitis Drug Market Size by Type
8.1.1 Asia Pacific Anterior Uveitis Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Anterior Uveitis Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Anterior Uveitis Drug Market Size by Application
8.2.1 Asia Pacific Anterior Uveitis Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Anterior Uveitis Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Anterior Uveitis Drug Market Size by Region
8.3.1 Asia Pacific Anterior Uveitis Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Anterior Uveitis Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Anterior Uveitis Drug Market Size by Type
9.1.1 Latin America Anterior Uveitis Drug Sales by Type (2017-2028)
9.1.2 Latin America Anterior Uveitis Drug Revenue by Type (2017-2028)
9.2 Latin America Anterior Uveitis Drug Market Size by Application
9.2.1 Latin America Anterior Uveitis Drug Sales by Application (2017-2028)
9.2.2 Latin America Anterior Uveitis Drug Revenue by Application (2017-2028)
9.3 Latin America Anterior Uveitis Drug Market Size by Country
9.3.1 Latin America Anterior Uveitis Drug Sales by Country (2017-2028)
9.3.2 Latin America Anterior Uveitis Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Anterior Uveitis Drug Market Size by Type
10.1.1 Middle East and Africa Anterior Uveitis Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Anterior Uveitis Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Anterior Uveitis Drug Market Size by Application
10.2.1 Middle East and Africa Anterior Uveitis Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Anterior Uveitis Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Anterior Uveitis Drug Market Size by Country
10.3.1 Middle East and Africa Anterior Uveitis Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Anterior Uveitis Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Aciont Inc.
11.1.1 Aciont Inc. Corporation Information
11.1.2 Aciont Inc. Overview
11.1.3 Aciont Inc. Anterior Uveitis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Aciont Inc. Anterior Uveitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Aciont Inc. Recent Developments
11.2 Aldeyra Therapeutics, Inc.
11.2.1 Aldeyra Therapeutics, Inc. Corporation Information
11.2.2 Aldeyra Therapeutics, Inc. Overview
11.2.3 Aldeyra Therapeutics, Inc. Anterior Uveitis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Aldeyra Therapeutics, Inc. Anterior Uveitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Aldeyra Therapeutics, Inc. Recent Developments
11.3 EyeGate Pharmaceuticals, Inc.
11.3.1 EyeGate Pharmaceuticals, Inc. Corporation Information
11.3.2 EyeGate Pharmaceuticals, Inc. Overview
11.3.3 EyeGate Pharmaceuticals, Inc. Anterior Uveitis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 EyeGate Pharmaceuticals, Inc. Anterior Uveitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 EyeGate Pharmaceuticals, Inc. Recent Developments
11.4 KPI Therapeutics, Inc.
11.4.1 KPI Therapeutics, Inc. Corporation Information
11.4.2 KPI Therapeutics, Inc. Overview
11.4.3 KPI Therapeutics, Inc. Anterior Uveitis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 KPI Therapeutics, Inc. Anterior Uveitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 KPI Therapeutics, Inc. Recent Developments
11.5 Neuroptis Biotech
11.5.1 Neuroptis Biotech Corporation Information
11.5.2 Neuroptis Biotech Overview
11.5.3 Neuroptis Biotech Anterior Uveitis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Neuroptis Biotech Anterior Uveitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Neuroptis Biotech Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Anterior Uveitis Drug Industry Chain Analysis
12.2 Anterior Uveitis Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anterior Uveitis Drug Production Mode & Process
12.4 Anterior Uveitis Drug Sales and Marketing
12.4.1 Anterior Uveitis Drug Sales Channels
12.4.2 Anterior Uveitis Drug Distributors
12.5 Anterior Uveitis Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Anterior Uveitis Drug Industry Trends
13.2 Anterior Uveitis Drug Market Drivers
13.3 Anterior Uveitis Drug Market Challenges
13.4 Anterior Uveitis Drug Market Restraints
14 Key Findings in The Global Anterior Uveitis Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Anterior Uveitis Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Dalazatide
Table 3. Major Manufacturers of LME-636
Table 4. Major Manufacturers of NOP-3
Table 5. Major Manufacturers of Others
Table 6. Global Anterior Uveitis Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Anterior Uveitis Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Anterior Uveitis Drug Sales by Region (2017-2022) & (K Pcs)
Table 9. Global Anterior Uveitis Drug Sales Market Share by Region (2017-2022)
Table 10. Global Anterior Uveitis Drug Sales by Region (2023-2028) & (K Pcs)
Table 11. Global Anterior Uveitis Drug Sales Market Share by Region (2023-2028)
Table 12. Global Anterior Uveitis Drug Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Anterior Uveitis Drug Revenue Market Share by Region (2017-2022)
Table 14. Global Anterior Uveitis Drug Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Anterior Uveitis Drug Revenue Market Share by Region (2023-2028)
Table 16. Global Anterior Uveitis Drug Sales by Manufacturers (2017-2022) & (K Pcs)
Table 17. Global Anterior Uveitis Drug Sales Share by Manufacturers (2017-2022)
Table 18. Global Anterior Uveitis Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Anterior Uveitis Drug Revenue Share by Manufacturers (2017-2022)
Table 20. Anterior Uveitis Drug Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 21. Global Anterior Uveitis Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Anterior Uveitis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anterior Uveitis Drug as of 2021)
Table 23. Anterior Uveitis Drug Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Anterior Uveitis Drug Product Offered
Table 25. Date of Manufacturers Enter into Anterior Uveitis Drug Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Anterior Uveitis Drug Sales by Type (2017-2022) & (K Pcs)
Table 28. Global Anterior Uveitis Drug Sales by Type (2023-2028) & (K Pcs)
Table 29. Global Anterior Uveitis Drug Sales Share by Type (2017-2022)
Table 30. Global Anterior Uveitis Drug Sales Share by Type (2023-2028)
Table 31. Global Anterior Uveitis Drug Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Anterior Uveitis Drug Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Anterior Uveitis Drug Revenue Share by Type (2017-2022)
Table 34. Global Anterior Uveitis Drug Revenue Share by Type (2023-2028)
Table 35. Anterior Uveitis Drug Price by Type (2017-2022) & (USD/Pcs)
Table 36. Global Anterior Uveitis Drug Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 37. Global Anterior Uveitis Drug Sales by Application (2017-2022) & (K Pcs)
Table 38. Global Anterior Uveitis Drug Sales by Application (2023-2028) & (K Pcs)
Table 39. Global Anterior Uveitis Drug Sales Share by Application (2017-2022)
Table 40. Global Anterior Uveitis Drug Sales Share by Application (2023-2028)
Table 41. Global Anterior Uveitis Drug Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Anterior Uveitis Drug Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Anterior Uveitis Drug Revenue Share by Application (2017-2022)
Table 44. Global Anterior Uveitis Drug Revenue Share by Application (2023-2028)
Table 45. Anterior Uveitis Drug Price by Application (2017-2022) & (USD/Pcs)
Table 46. Global Anterior Uveitis Drug Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 47. North America Anterior Uveitis Drug Sales by Type (2017-2022) & (K Pcs)
Table 48. North America Anterior Uveitis Drug Sales by Type (2023-2028) & (K Pcs)
Table 49. North America Anterior Uveitis Drug Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Anterior Uveitis Drug Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Anterior Uveitis Drug Sales by Application (2017-2022) & (K Pcs)
Table 52. North America Anterior Uveitis Drug Sales by Application (2023-2028) & (K Pcs)
Table 53. North America Anterior Uveitis Drug Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Anterior Uveitis Drug Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Anterior Uveitis Drug Sales by Country (2017-2022) & (K Pcs)
Table 56. North America Anterior Uveitis Drug Sales by Country (2023-2028) & (K Pcs)
Table 57. North America Anterior Uveitis Drug Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Anterior Uveitis Drug Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Anterior Uveitis Drug Sales by Type (2017-2022) & (K Pcs)
Table 60. Europe Anterior Uveitis Drug Sales by Type (2023-2028) & (K Pcs)
Table 61. Europe Anterior Uveitis Drug Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Anterior Uveitis Drug Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Anterior Uveitis Drug Sales by Application (2017-2022) & (K Pcs)
Table 64. Europe Anterior Uveitis Drug Sales by Application (2023-2028) & (K Pcs)
Table 65. Europe Anterior Uveitis Drug Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Anterior Uveitis Drug Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Anterior Uveitis Drug Sales by Country (2017-2022) & (K Pcs)
Table 68. Europe Anterior Uveitis Drug Sales by Country (2023-2028) & (K Pcs)
Table 69. Europe Anterior Uveitis Drug Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Anterior Uveitis Drug Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Anterior Uveitis Drug Sales by Type (2017-2022) & (K Pcs)
Table 72. Asia Pacific Anterior Uveitis Drug Sales by Type (2023-2028) & (K Pcs)
Table 73. Asia Pacific Anterior Uveitis Drug Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Anterior Uveitis Drug Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Anterior Uveitis Drug Sales by Application (2017-2022) & (K Pcs)
Table 76. Asia Pacific Anterior Uveitis Drug Sales by Application (2023-2028) & (K Pcs)
Table 77. Asia Pacific Anterior Uveitis Drug Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Anterior Uveitis Drug Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Anterior Uveitis Drug Sales by Region (2017-2022) & (K Pcs)
Table 80. Asia Pacific Anterior Uveitis Drug Sales by Region (2023-2028) & (K Pcs)
Table 81. Asia Pacific Anterior Uveitis Drug Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Anterior Uveitis Drug Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Anterior Uveitis Drug Sales by Type (2017-2022) & (K Pcs)
Table 84. Latin America Anterior Uveitis Drug Sales by Type (2023-2028) & (K Pcs)
Table 85. Latin America Anterior Uveitis Drug Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Anterior Uveitis Drug Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Anterior Uveitis Drug Sales by Application (2017-2022) & (K Pcs)
Table 88. Latin America Anterior Uveitis Drug Sales by Application (2023-2028) & (K Pcs)
Table 89. Latin America Anterior Uveitis Drug Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Anterior Uveitis Drug Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Anterior Uveitis Drug Sales by Country (2017-2022) & (K Pcs)
Table 92. Latin America Anterior Uveitis Drug Sales by Country (2023-2028) & (K Pcs)
Table 93. Latin America Anterior Uveitis Drug Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Anterior Uveitis Drug Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Anterior Uveitis Drug Sales by Type (2017-2022) & (K Pcs)
Table 96. Middle East and Africa Anterior Uveitis Drug Sales by Type (2023-2028) & (K Pcs)
Table 97. Middle East and Africa Anterior Uveitis Drug Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Anterior Uveitis Drug Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Anterior Uveitis Drug Sales by Application (2017-2022) & (K Pcs)
Table 100. Middle East and Africa Anterior Uveitis Drug Sales by Application (2023-2028) & (K Pcs)
Table 101. Middle East and Africa Anterior Uveitis Drug Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Anterior Uveitis Drug Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Anterior Uveitis Drug Sales by Country (2017-2022) & (K Pcs)
Table 104. Middle East and Africa Anterior Uveitis Drug Sales by Country (2023-2028) & (K Pcs)
Table 105. Middle East and Africa Anterior Uveitis Drug Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Anterior Uveitis Drug Revenue by Country (2023-2028) & (US$ Million)
Table 107. Aciont Inc. Corporation Information
Table 108. Aciont Inc. Description and Major Businesses
Table 109. Aciont Inc. Anterior Uveitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 110. Aciont Inc. Anterior Uveitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Aciont Inc. Recent Developments
Table 112. Aldeyra Therapeutics, Inc. Corporation Information
Table 113. Aldeyra Therapeutics, Inc. Description and Major Businesses
Table 114. Aldeyra Therapeutics, Inc. Anterior Uveitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 115. Aldeyra Therapeutics, Inc. Anterior Uveitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Aldeyra Therapeutics, Inc. Recent Developments
Table 117. EyeGate Pharmaceuticals, Inc. Corporation Information
Table 118. EyeGate Pharmaceuticals, Inc. Description and Major Businesses
Table 119. EyeGate Pharmaceuticals, Inc. Anterior Uveitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 120. EyeGate Pharmaceuticals, Inc. Anterior Uveitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. EyeGate Pharmaceuticals, Inc. Recent Developments
Table 122. KPI Therapeutics, Inc. Corporation Information
Table 123. KPI Therapeutics, Inc. Description and Major Businesses
Table 124. KPI Therapeutics, Inc. Anterior Uveitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 125. KPI Therapeutics, Inc. Anterior Uveitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. KPI Therapeutics, Inc. Recent Developments
Table 127. Neuroptis Biotech Corporation Information
Table 128. Neuroptis Biotech Description and Major Businesses
Table 129. Neuroptis Biotech Anterior Uveitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 130. Neuroptis Biotech Anterior Uveitis Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Neuroptis Biotech Recent Developments
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Anterior Uveitis Drug Distributors List
Table 135. Anterior Uveitis Drug Customers List
Table 136. Anterior Uveitis Drug Market Trends
Table 137. Anterior Uveitis Drug Market Drivers
Table 138. Anterior Uveitis Drug Market Challenges
Table 139. Anterior Uveitis Drug Market Restraints
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Anterior Uveitis Drug Product Picture
Figure 3. Global Anterior Uveitis Drug Market Share by Type in 2021 & 2028
Figure 3. Dalazatide Product Picture
Figure 4. LME-636 Product Picture
Figure 5. NOP-3 Product Picture
Figure 6. Others Product Picture
Figure 7. Global Anterior Uveitis Drug Market Share by Application in 2021 & 2028
Figure 8. Clinic
Figure 9. Hospital
Figure 10. Others
Figure 11. Anterior Uveitis Drug Report Years Considered
Figure 12. Global Anterior Uveitis Drug Sales 2017-2028 (K Pcs)
Figure 13. Global Anterior Uveitis Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Anterior Uveitis Drug Revenue 2017-2028 (US$ Million)
Figure 15. Global Anterior Uveitis Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Anterior Uveitis Drug Sales Market Share by Region (2017-2022)
Figure 17. Global Anterior Uveitis Drug Sales Market Share by Region (2023-2028)
Figure 18. North America Anterior Uveitis Drug Sales YoY (2017-2028) & (K Pcs)
Figure 19. North America Anterior Uveitis Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Anterior Uveitis Drug Sales YoY (2017-2028) & (K Pcs)
Figure 21. Europe Anterior Uveitis Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Anterior Uveitis Drug Sales YoY (2017-2028) & (K Pcs)
Figure 23. Asia-Pacific Anterior Uveitis Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Anterior Uveitis Drug Sales YoY (2017-2028) & (K Pcs)
Figure 25. Latin America Anterior Uveitis Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Anterior Uveitis Drug Sales YoY (2017-2028) & (K Pcs)
Figure 27. Middle East & Africa Anterior Uveitis Drug Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Anterior Uveitis Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Anterior Uveitis Drug in the World: Market Share by Anterior Uveitis Drug Revenue in 2021
Figure 30. Global Anterior Uveitis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Anterior Uveitis Drug Sales Market Share by Type (2017-2028)
Figure 32. Global Anterior Uveitis Drug Revenue Market Share by Type (2017-2028)
Figure 33. Global Anterior Uveitis Drug Sales Market Share by Application (2017-2028)
Figure 34. Global Anterior Uveitis Drug Revenue Market Share by Application (2017-2028)
Figure 35. North America Anterior Uveitis Drug Sales Market Share by Type (2017-2028)
Figure 36. North America Anterior Uveitis Drug Revenue Market Share by Type (2017-2028)
Figure 37. North America Anterior Uveitis Drug Sales Market Share by Application (2017-2028)
Figure 38. North America Anterior Uveitis Drug Revenue Market Share by Application (2017-2028)
Figure 39. North America Anterior Uveitis Drug Sales Share by Country (2017-2028)
Figure 40. North America Anterior Uveitis Drug Revenue Share by Country (2017-2028)
Figure 41. U.S. Anterior Uveitis Drug Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Anterior Uveitis Drug Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Anterior Uveitis Drug Sales Market Share by Type (2017-2028)
Figure 44. Europe Anterior Uveitis Drug Revenue Market Share by Type (2017-2028)
Figure 45. Europe Anterior Uveitis Drug Sales Market Share by Application (2017-2028)
Figure 46. Europe Anterior Uveitis Drug Revenue Market Share by Application (2017-2028)
Figure 47. Europe Anterior Uveitis Drug Sales Share by Country (2017-2028)
Figure 48. Europe Anterior Uveitis Drug Revenue Share by Country (2017-2028)
Figure 49. Germany Anterior Uveitis Drug Revenue (2017-2028) & (US$ Million)
Figure 50. France Anterior Uveitis Drug Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Anterior Uveitis Drug Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Anterior Uveitis Drug Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Anterior Uveitis Drug Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Anterior Uveitis Drug Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Anterior Uveitis Drug Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Anterior Uveitis Drug Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Anterior Uveitis Drug Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Anterior Uveitis Drug Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Anterior Uveitis Drug Revenue Share by Region (2017-2028)
Figure 60. China Anterior Uveitis Drug Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Anterior Uveitis Drug Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Anterior Uveitis Drug Revenue (2017-2028) & (US$ Million)
Figure 63. India Anterior Uveitis Drug Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Anterior Uveitis Drug Revenue (2017-2028) & (US$ Million)
Figure 65. Taiwan Anterior Uveitis Drug Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Anterior Uveitis Drug Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Anterior Uveitis Drug Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Anterior Uveitis Drug Revenue (2017-2028) & (US$ Million)
Figure 69. Philippines Anterior Uveitis Drug Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Anterior Uveitis Drug Sales Market Share by Type (2017-2028)
Figure 71. Latin America Anterior Uveitis Drug Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Anterior Uveitis Drug Sales Market Share by Application (2017-2028)
Figure 73. Latin America Anterior Uveitis Drug Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Anterior Uveitis Drug Sales Share by Country (2017-2028)
Figure 75. Latin America Anterior Uveitis Drug Revenue Share by Country (2017-2028)
Figure 76. Mexico Anterior Uveitis Drug Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Anterior Uveitis Drug Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Anterior Uveitis Drug Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Anterior Uveitis Drug Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Anterior Uveitis Drug Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Anterior Uveitis Drug Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Anterior Uveitis Drug Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Anterior Uveitis Drug Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Anterior Uveitis Drug Revenue Share by Country (2017-2028)
Figure 85. Turkey Anterior Uveitis Drug Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Anterior Uveitis Drug Revenue (2017-2028) & (US$ Million)
Figure 87. U.A.E Anterior Uveitis Drug Revenue (2017-2028) & (US$ Million)
Figure 88. Anterior Uveitis Drug Value Chain
Figure 89. Anterior Uveitis Drug Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed